Pharmaceutical Softgels
Our Ayanda plant in Germany has a broad experience in manufacturing Softgels for medicinal use.
1996, Ayanda received the manufacturing authorization based on German Medicinal Products Act (AMG § 13), allowing to produce pharmaceutical Softgels in line with European GMP.
Since this time, we successfully conducted many pharmaceutical product transfers and also developed – based on marketing authorization of clients – generic Softgel formulations.
Our Ayanda plant in Germany has a broad experience in manufacturing Softgels for medicinal use.
1996, Ayanda received the manufacturing authorization based on German Medicinal Products Act (AMG § 13), allowing to produce pharmaceutical Softgels in line with European GMP.
Since this time, we successfully conducted many pharmaceutical product transfers and also developed – based on marketing authorization of clients – generic Softgel formulations.
Prior to starting a development or transfer of a medicinal product, we prepare and agree with our clients on a joint project plan highlighting tasks and milestones. We thoroughly assess API, regulatory, analytical and manufacturing requirements, based on documents provided and our experience. It is important for us to collaborate closely with our customers and be transparent in every step we do.
We are proud of the many long-term partnerships we have entered into in connection with the manufacture of pharmaceutical softgels. And we never forget the patient for whom these medicines are made.
